(a) Schedule I consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(b) Opiates, unless specifically excepted or unless listed in another schedule, means any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; provided, that for the purposes of subdivision (b)(48)(B)(xv), 3-Methylfentanyl, only, “isomer” includes the optical and geometric isomers:

(1) Acetylmethadol;

(2) Allylprodine;

(3) Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol; levomethadyl acetate; or LAAM);

(4) Alphameprodine;

(5) Alphamethadol;

(6) Benzethidine;

(7) Betacetylmethadol;

(8) Betameprodine;

(9) Betamethadol;

(10) Betaprodine;

(11) Clonitazene;

(12) Dextromoramide;

(13) Diampromide;

(14) Diethylthiambutene;

(15) Difenoxin;

(16) Dimenoxadol;

(17) Dimepheptanol;

(18) Dimethylthiambutene;

(19) Dioxaphetyl butyrate;

(20) Dipipanone;

(21) Ethylmethylthiambutene;

(22) Etonitazene;

(23) Etoxeridine;

(24) Furethidine;

(25) Hydroxypethidine;

(26) Ketobemidone;

(27) Levomoramide;

(28) Levophenacylmorphan;

(29) Morpheridine;

(30) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

(31) Noracymethadol;

(32) Norlevorphanol;

(33) Normethadone;

(34) Norpipanone;

(35) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);

(36) Phenadoxone;

(37) Phenampromide;

(38) Phenomorphan;

(39) Phenoperidine;

(40) Piritramide;

(41) Proheptazine;

(42) Properidine;

(43) Propiram;

(44) Racemoramide;

(45) Tilidine;

(46) Trimeperidine;

(47) U-47700; or

(48) Fentanyl derivatives and analogues:

(A) Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States food and drug administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations containing a 4-anilidopiperidine structure:

(i) With or without substitution at the carbonyl of the aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl, methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl, dihydrofuranyl, benzyl moiety, or rings containing heteroatoms sulfur, oxygen, or nitrogen;

(ii) With or without substitution at the piperidine amino moiety with a phenethyl, benzyl, alkylaryl (including heteroaromatics), alkyltetrazolyl ring, or an alkyl or carbomethoxy group, whether or not further substituted in the ring or group;

(iii) With or without substitution or addition to the piperdine ring to any extent with one or more methyl, carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester groups;

(iv) With or without substitution of one or more hydrogen atoms for halogens, or methyl, alkyl, or methoxy groups, in the aromatic ring of the anilide moiety;

(v) With or without substitution at the alpha or beta position of the piperidine ring with alkyl, hydroxyl, or methoxy groups;

(vi) With or without substitution of the benzene ring of the anilide moiety for an aromatic heterocycle; or

(vii) With or without substitution of the piperidine ring for a pyrrolidine ring, perhydroazepine ring, or azepine ring; and

(B) The application of subdivision (b)(48)(A) includes, but is not limited to, any of the following:

(i) Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);

(ii) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidnyl]-N-phenyl-acetamide);

(iii) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide);

(iv) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);

(v) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

(vi) Benzodioxolefentanyl;

(vii) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);

(viii) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide); N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide);

(ix) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);

(x) Butyrylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

(xi) Cyclopentyl fentanyl;

(xii) Isobutyryl fentanyl;

(xiii) Furanyl fentanyl;

(xiv) Lofentanil;

(xv) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);

(xvi) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

(xvii) Ocfentanil;

(xviii) Ohmefentanyl;

(xix) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide);

(xx) Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; 4-fluoroisobutyryl fentanyl;

(xxi) Pentanoyl fentanyl;

(xxii) Thiofentanyl; or

(xxiii) Valeryl fentanyl.

(c) Opium derivatives, unless specifically excepted or unless listed in another schedule, means any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Acetorphine;

(2) Acetyldihydrocodeine;

(3) Benzylmorphine;

(4) Codeine methylbromide;

(5) Codeine-N-Oxide;

(6) Cyprenorphine;

(7) Desomorphine;

(8) Dihydromorphine;

(9) Drotebanol;

(10) Etorphine (except hydrochloride salt);

(11) Heroin;

(12) Hydromorphinol;

(13) Methyldesorphine;

(14) Methyldihydromorphine;

(15) Morphine methylbromide;

(16) Morphine methylsulfonate;

(17) Morphine-N-Oxide;

(18) Myrophine;

(19) Nicocodeine;

(20) Nicomorphine;

(21) Normorphine;

(22) Pholcodine; or

(23) Thebacon.

(d) Hallucinogenic substances, unless specifically excepted or unless listed in another schedule, means any material, compound mixture, or preparation that contains any quantity of the following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation; provided, that for purposes of this subsection (d) only, “isomer” includes the optical, positional, and geometric isomers:

(1) Alpha-ethyltryptamine

(2) Alpha-methyltryptamine

(3) 4-Bromo-2,5-dimethoxyamphetamine

(4) 4-Bromo-2,5-dimethoxyphenethylamine

(5) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

(6) Bufotenine

(7) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

(8) Diethyltryptamine

(9) 2,5-Dimethoxyamphetamine

(10) 2,5-Dimethoxy-4-ethylamphetamine

(11) 2,5 Dimethoxy-4-(n)-propylthiophenethylamine

(12) Dimethyltryptamine

(13) Ethylamine analogue of phencyclidine

(14) Ibogaine

(15) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

(16) Lysergic acid diethylamide

(17) Mescaline

(18) 4-Methoxyamphetamine

(19) 5-Methoxy-3,4-methylenedioxyamphetamine;

(20) 5-Methoxy-N,N-diisopropyltryptamine

(21) 5-methoxy-N,N-dimethyltryptamine

(22) 4-Methyl-2,5-dimethoxyamphetamine

(23) 3,4-Methylenedioxyamphetamine;

(24) 3,4-Methylenedioxymethamphetamine

(25) 3,4-Methylenedioxy-N-ethylamphetamine

(26) 3,4-Methylenedioxy-N-methylcathinone

(27) N-Ethyl-3-piperidyl benzilate;

(28) N-Hydroxy-3,4-methylenedioxyamphetamine

(29) N-methyl-3-piperidyl benzilate;

(30) Parahexyl

(31) Peyote

(32) Psilocybin (constituent of magic mushrooms);

(33) Psilocyn (constituent of magic mushrooms);

(34) Pyrrolidine analogue of phencyclidine (1-(1-phenylcyclohexyl)-pyrrolidine)

(35) 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine

(36) 4-Methylmethcathinone

(37) 3,4-Methylenedioxypyrovalerone

(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);

(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);

(40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);

(41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);

(42) 2-[4-Ethylthio-2,5-dimethoxyphenyl]ethanamine (2C-T-2);

(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);

(44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);

(45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);

(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);

(47) Thiophene analogue of phencyclidine

(48) 3,4,5-Trimethoxyamphetamine;

(49) (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(50) [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone

(e) Depressants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation:

(1) Etizolam

(2) Gamma-hydroxybutyric acid

(3) Mecloqualone; or

(4) Methaqualone.

(f) Stimulants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

(1) Alpha-pyrrolidinobutiophenone

(2) Alpha-pyrrolidinopentiophenone

(3) Aminorex

(4) Butylone

(5) Cathinone

(6) 3-Fluoro-N-methylcathinone

(7) 4-Fluoro-N-methylcathinone

(8) Fenethylline;

(9) Methcathinone

(10) (+/-)cis-4-Methylaminorex (cis isomer)

(11) 4-Methyl-N-ethylcathinone

(12) 4-Methyl-alpha-pyrrolidinopropiophenone

(13) Naphyrone

(14) N-Benzylpiperazine

(15) N-Ethylamphetamine;

(16) N,N-Dimethylamphetamine

(17) Pentedrone

(18) Pentylone

(g) Cannabimimetic agents, unless specifically exempted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances, or that contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);

(2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);

(3) 1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);

(4) 1-Butyl-3-(1-naphthoyl)indole (JWH-073);

(5) 1-Hexyl-3-(1-naphthoyl)indole (JWH-019);

(6) 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);

(7) 1-Pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);

(8) 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);

(9) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);

(10) 1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);

(11) (1-(5-Fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ-2201);

(12) 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201);

(13) 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);

(14) 1-Pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);

(15) 1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8);

(16) 1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH-203);

(17) Methyl 2-(1-(cyclohexylmethyl)-1h-indole-3-carboxamido)-3,3-dimethylbutanoate

(18) Methyl 2-(1-(4-fluorobenzyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate

(19) Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3-methylbutanoate

(20) Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate

(21) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide

(22) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

(23) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide

(24) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3-carboxamide

(25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)1H-indazole-3-carboxamide

(26) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

(27) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

(28) Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

(29) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate